SCHEMBL1913115

SCHEMBL1913115

CCc1cccc(C)c1-c1nc(Cl)c(CN(Cc2ccccc2)CC(C)(C)C)n1CCOC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 3/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ CRHR1 P34998 2/20 0.33
▸ CASR P41180 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ ALDH1A1 P00352 6/20 0.33
▸ KDM4E B2RXH2 5/20 0.33
▸ HSD17B10 Q99714 3/20 0.32
▸ GAA P10253 4/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ MAPT P10636 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ PKM P14618 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL652707 0.95 USP2 (0.39) USP2SMN1; SMN2CRHR1HPGDALDH1A1
SCHEMBL1918604 0.92 USP2 (0.38) USP2SMN1; SMN2CRHR1CASRHPGD
SCHEMBL651107 0.88 TSHR (0.38) USP2SMN1; SMN2HPGDALDH1A1KDM4E
SCHEMBL648275 0.84 TLR7 (0.34) USP2ALDH1A1HSD17B10
SCHEMBL650433 0.78 CRHR1 (0.36) USP2CRHR1CASRHPGDALDH1A1
SCHEMBL649555 0.76 SMN1; SMN2 (0.35) USP2SMN1; SMN2CRHR1CASRALDH1A1
SCHEMBL5929010 0.74 ALDH1A1 (0.35) USP2CASRHPGDALDH1A1HSD17B10
SCHEMBL649322 0.73 SQLE (0.35) —
SCHEMBL1912823 0.71 ALDH1A1 (0.47) USP2SMN1; SMN2CASRHPGDALDH1A1
SCHEMBL648638 0.71 KMT2A (0.32) CRHR1MEN1KMT2APTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 — — US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 — — US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 — — US disclosed
Send feedback